The potential mechanism of Huangqin for treatment of systemic lupus erythematosus based on network pharmacology, molecular docking and molecular dynamics simulation
Der mögliche Mechanismus von Huangqin zur Behandlung des systemischen Lupus erythematodes basierend auf Network Pharmacology, Molecular Docking und Molekulardynamik-Simulation
PeerJ · 26.06.2025 · 13 · e19536
DOI: 10.7717/peerj.19536 ↗Auf einen Blick
Die Studie analysierte Huangqin (Scutellaria baicalensis) bei SLE. Genannt werden 36 aktive Komponenten, 28 gemeinsame Targets und mögliche Signalwege; experimentelle Wirksamkeitsdaten fehlen.
Fragestellung
Welche wirksamen Inhaltsstoffe und Zielstrukturen von Huangqin sind mit der Behandlung von systemischem Lupus erythematodes (SLE) verbunden?
Methode
Network-Pharmacology-Analyse mit TCMSP, GeneCards, KEGG, GEO, STRING, Cytoscape und DAVID; zusätzlich Molecular Docking und Molekulardynamik-Simulation.
Ergebnisse
36 aktive Komponenten und 512 Drug Targets wurden identifiziert, dazu 1.439 SLE-Targets und 28 gemeinsame Targets. Wichtige Komponenten waren baicalin, acacetin, oroxylin a, neobaicalin und stigmasterol.
Schlussfolgerung der Autor:innen
Huangqin kann SLE über wirksame Komponenten wie baicalin und acacetin behandeln. Der Mechanismus umfasst laut Autor:innen die Hemmung inflammatorischer Faktoren, Einflüsse auf Immunzellen und Autophagie.
Kernaussagen
- 36 aktive Komponenten und 28 gemeinsame Targets wurden identifiziert.
- Wichtige Gene: IL6, CASP3, BCL2, ESR1 und FOS.
- Genannte Signalwege: HIF-1, PI3K-AKT, MAPK und IL-17.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, online erschienen am 26.06.2025. Verfasst von Shuting Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Drugs, Chinese Herbal, Network Pharmacology. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Project of Guangdong Provincial Bureau of Traditional Chinese Medicine, Guangzhou Science and Technology Bureau Young Doctor Program.
Abstract (Originalsprache)
Background
Systemic lupus erythematosus (SLE) is an autoimmune disease that cannot be cured at present. The primary treatment strategies for SLE include glucocorticoids, immunosuppressants, antimalarial drugs, and biologics. There is an urgent need for milder and more effective treatment methods. This study aims to explore the effective ingredients and targets of traditional Chinese medicine Scutellaria baicalensis (Huangqin) in the treatment of systemic lupus erythematosus based on network pharmacology, and further analyze the potential mechanisms of action.
Method
Employing the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) database to identify the active chemical components of Huangqin, searching for target genes related to SLE through GeneCards and the KEGG database, extracting the SLE expression gene profile from the GEO database to identify SLE-related targets, and identifying Huangqin-SLE interaction targets using Venny diagrams; Constructing protein interaction networks using the STRING database, identifying core targets with Cytoscape software, and conducting protein clustering analysis; Importing the common targets into the Database for Annotation, Visualization and Integrated Discovery (DAVID) for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Molecular docking was carried out by AutoDockTools, AutoDock Vina, and Discovery Studio software to verify the correlation between the main components of Huangqin and the core targets. Molecular dynamics simulations further confirmed the stability of the binding between components and the targets.
Results
Network pharmacology identified 36 active components and 512 drug targets in Huangqin, resulting in the identification of 1,439 SLE targets and 28 common targets. The primary active components are baicalin, acacetin, oroxylin a, neobaicalin, and stigmasterol. Key genes were IL6, CASP3, BCL2, ESR1, and FOS; GO enrichment analysis yielded 77 significant results, while KEGG enrichment analysis produced 64 significant results. The primary signaling pathways targeted by Huangqin in SLE include the HIF-1 signaling pathway, PI3K-AKt signaling pathway, MAPK signaling pathway, IL-17 signaling pathway. Results of molecular docking indicated good binding affinity of Huangqin to stigmastero, baicalein and acacetin. The dynamics simulation indicated that the four complexes possessed reliable structural stability and compactness.
Conclusion
Huangqin can treat SLE through its effective components such as baicalin and acacetin. The mechanism involves inhibiting inflammatory factors, affecting the expression and activation of immune cells, and regulating cell autophagy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
- Department of Rheumatology and immunology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia Hui Autonomous Region, China.
Förderung
- Scientific Research Project of Guangdong Provincial Bureau of Traditional Chinese Medicine
- Guangzhou Science and Technology Bureau Young Doctor Program
Zitieren
APA
Zheng, S., Yang, H., Wu, J., Jin, O., & Zhang, X. (2025). The potential mechanism of Huangqin for treatment of systemic lupus erythematosus based on network pharmacology, molecular docking and molecular dynamics simulation. PeerJ, 13, e19536. https://doi.org/10.7717/peerj.19536
Vancouver
Zheng S, Yang H, Wu J, Jin O, Zhang X. The potential mechanism of Huangqin for treatment of systemic lupus erythematosus based on network pharmacology, molecular docking and molecular dynamics simulation. PeerJ. 2025;13:e19536. doi:10.7717/peerj.19536
BibTeX
@article{Zheng2025,
author = {Zheng, Shuting and Yang, Hui and Wu, Jialing and Jin, Ou and Zhang, Xi},
title = {The potential mechanism of Huangqin for treatment of systemic lupus erythematosus based on network pharmacology, molecular docking and molecular dynamics simulation},
journal = {PeerJ},
year = {2025},
volume = {13},
pages = {e19536},
doi = {10.7717/peerj.19536}
}
EUVIMED